Search results for "oral lichen planus"

showing 10 items of 111 documents

A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in…

2004

Summary Background  Topical application of clobetasol-17-propionate has been diffusely reported as an efficacious therapy in atrophic/erosive oral lichen planus (OLP), without exposing the patient to systemic side-effects. However, prolonged contact and respective topical effects on the oral mucosa should be avoided. Objectives  The aim of the present study was to evaluate efficacy and compliance of new lipid microspheres loaded with 0·025% of clobetasol propionate (formulation A) compared with a commonly used formulation (a sort of dispersion of a lipophilic ointment in a hydrophilic phase) with the same amount of drug (formulation B) in the topical treatment of OLP. Patients and methods  …

AdultMalemedicine.medical_specialtyRandomizationVisual analogue scaleAdministration TopicalChemistry PharmaceuticalAnti-Inflammatory AgentsDermatologyDosage formlaw.inventionOintmentsDrug Delivery SystemsRandomized controlled triallawMedicineHumansSingle-Blind MethodOral mucosaGlucocorticoidsAgedAged 80 and overClobetasolbusiness.industryMiddle Agedmedicine.diseaseDermatologyLipidsMicrospheresRegimenmedicine.anatomical_structureclobetasol propionate delivery lipid microspheres oral lichen planusPatient ComplianceOral lichen planusFemaleClobetasol propionatebusinessmedicine.drugLichen Planus OralThe British journal of dermatology
researchProduct

Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus.

2008

Background Oral lichen planus (OLP) is considered to be an autoimmune disease of unknown aetiology that affects the mucosae, especially the oral cavity. Objective We compared tacrolimus 0.1% ointment and clobetasol 0.05% ointment for the treatment of OLP. Patients and methods A total of 32 patients (20 females and 12 males; all white, Italian origin, mean age of 43.6+/-18.4 years; 16 patients per treatment group) were treated with tacrolimus or clobetasol ointment for 4 weeks in a randomized, double-blind, clinical trial. Pain severity, burning sensation, and mucosal lesion extension were assessed using a four-point scale. Results At the end of the treatment period, symptom scores were sign…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_classAnti-Inflammatory Agentstacrolimus ointment; clobetasol ointment; oral lichen planuslaw.inventionOintment Basesoral lichen planusRandomized controlled triallawOral administrationFacial PainmedicineHumanstacrolimus ointmentSalivatacrolimusbusiness.industryclobetasol ointmentclobetasol; tacrolimus; oral lichen planusmedicine.diseaseDermatologyTacrolimusCalcineurinstomatognathic diseasesclobetasolOintment BasesPeriodonticsCorticosteroidOral lichen planusFemaleClobetasol propionatebusinessEpidemiologic MethodsImmunosuppressive Agentsmedicine.drugLichen Planus Oral
researchProduct

A retrospective study of 370 patients with oral lichen planus in Turkey.

2012

Objectives: Although several detailed studies concerning the patient profile and clinical features of oral lichen planus have been undertaken all over the world in different populations, a similar study has not yet been conducted in a Turkish population. The purpose of this retrospective study was to describe the demographic and clinical characteristics of a group of patients with oral lichen planus in Turkey. Study Design: Charts of 370 patients, from the archive of Oral Diagnosis and Radiology Department of Marmara University Faculty of Dentistry (Istanbul, Turkey), with histologically confirmed clinical diagnosis of oral lichen planus in the period 1990-2010 were retrospectively reviewed…

AdultMalemedicine.medical_specialtyTurkish populationAdolescentTurkeyDentistryOdontologíaAsymptomaticYoung Adultstomatognathic systemmedicineHumansOral DiagnosisYoung adultskin and connective tissue diseasesGeneral DentistryAgedRetrospective StudiesAged 80 and overOral Medicine and Pathologyintegumentary systembusiness.industryRetrospective cohort studyMean ageMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologyCiencias de la saludstomatognathic diseasesOtorhinolaryngologyClinical diagnosisUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusFemaleResearch-Articlemedicine.symptombusinessLichen Planus OralMedicina oral, patologia oral y cirugia bucal
researchProduct

Possible link between Hashimoto's thyroiditis and oral lichen planus: a novel association found

2013

Objectives: Hashimoto's thyroiditis as well as lichen planus has been associated to a number of disorders, generally of auto-immune origin. A novel possible association between oral lichen planus (OLP) and Hashimoto's thyroiditis (HT) is here proposed on the basis of a cross-sectional survey. Materials and methods: One hundred and five unrelated OLP patients were considered. Diagnosis of HT was based on positive serum anti-TPO, anti-Tg, TSH levels and the typical ultrasound pattern of the thyroid gland. Results: In the present survey, the prevalence of HT in the OLP group was 14. 3 % whereas the prevalence of HT-related hypothyroidism in the general population was reported to be equal to 1 …

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesPopulationThyrotropinAutoimmunityHashimoto Diseasemedicine.disease_causeAutoantigensIodide PeroxidaseGastroenterologyAsymptomaticThyroiditisAutoimmunityHashimoto's thyroiditistomatognathic systemSettore MED/28 - Malattie OdontostomatologicheIron-Binding ProteinsInternal medicinePrevalencemedicineHumansThyroid NoduleOral mucosaeducationGeneral DentistryAutoantibodieseducation.field_of_studybusiness.industryThyroidMiddle AgedCirculating thyroid antibodiesmedicine.diseaseAnti-thyroid autoantibodiesThyroxinestomatognathic diseasesCross-Sectional Studiesmedicine.anatomical_structureItalyOral lichen planuHashimoto's thyroiditis; Oral lichen planus; Autoimmunity; Circulating thyroid antibodiesTriiodothyronineFemaleOral lichen planusmedicine.symptombusinessLichen Planus OralClinical Oral Investigations
researchProduct

Unexpected high frequency of genital involvement in women with clinical and hostological features of oral lichen planus

2006

The main aims of this cross-sectional study were: (i) to assess the frequency of genital (vulval) lichen planus (VLP) and vulval lichen sclerosus (VLS) in women affected with oral lichen planus (OLP), regardless of the genital symptoms reported; and (ii) to verify whether any demographic, clinical, or histological features of OLP are associated with a higher risk of vulvo-vaginal involvement. Fifty-five women, presenting OLP, consecutively underwent gynaecological examination and, if they demonstrated positive clinical signs of VLP, underwent biopsy. After a drop-out of 14 subjects, 31/41 (75.6%) were found to have signs of genital involvement, of which 13/31 (44.0%) were asymptomatic. Foll…

Adultmedicine.medical_specialtyDermatologyLichen sclerosusSettore MED/08 - Anatomia PatologicaAsymptomaticVulvar Lichen Sclerosusoral lichen planuTherapeutic approachstomatognathic systemSettore MED/28 - Malattie OdontostomatologicheBiopsyoral lichen planus; genital lichen planusgenital lichen planusMedicineHumansSex organAgedAged 80 and overmedicine.diagnostic_testbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseDermatologySettore MED/40 - Ginecologia E Ostetriciastomatognathic diseasesGynaecological examinationCross-Sectional StudiesOral lichen planusFemaleVulvar DiseasesMultivariate statisticalmedicine.symptombusinessLichen Planus Oral
researchProduct

Role of interleukin-4 in pathogenesis of oral lichen planus : a systematic review

2020

Background Oral lichen planus (OLP) is a premalignant mucocutaneous disease that affects 1-2% of the adult population. Immunological factor may act as etiological factor. The cellular immune cells such as T cells are important in pathogenesis of OLP. Interleukin-4 (IL-4) is secreted by T-helper 2 (Th2). Several studies have been carried out on the role of IL-4 in OLP. The aim of this study was to review the level of IL-4 in OLP, effective factors in the production of IL-4 and its role in the development of OLP. Material and Methods A search in PubMed was performed on the literature published from 2000 until august 2019 using the following keywords: “oral lichen planus” or “OLP” and “interle…

Adultmedicine.medical_specialtymedicine.medical_treatmentMucocutaneous zoneDiseaseReviewPathogenesisstomatognathic systemmedicineHumansGeneral DentistryInterleukin 4Oral Medicine and Pathologybusiness.industryCase-control studymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Dermatologystomatognathic diseasesCytokineOtorhinolaryngologyCase-Control StudiesUNESCO::CIENCIAS MÉDICASEtiologyCytokinesSurgeryOral lichen planusInterleukin-4businessPrecancerous ConditionsLichen Planus Oral
researchProduct

A combined treatment regimen for desquamative gingivitis in patients with oral lichen planus

2007

Background:  Chronic desquamative gingivitis (DG) is a condition characterized by erythema, ulceration, and desquamation of the free and attached gingiva, usually expression of a district-systemic disease, such as oral lichen planus (OLP). Methods:  A combined protocol of oral hygiene and topic corticosteroid therapy was applied in 30 patients with DG associated with OLP. Plaque index (PI) and bleeding on probing (BoP) were evaluated at baseline and after 3 months. Results:  PI scoring was significantly lower after treatment in anterior, posterior, and all sites (P < 0.0001) as well as in vestibular and lingual ones (P < 0.0001 and P = 0.0001, respectively). BoP measures were found to be re…

Cancer Researchmedicine.medical_specialtyErythemabusiness.industryBleeding on probingDentistrymedicine.diseaseDental plaqueOral hygieneGastroenterologyPathology and Forensic MedicineDesquamative gingivitisstomatognathic diseasesGingivitisstomatognathic systemOtorhinolaryngologyInternal medicineOral and maxillofacial pathologymedicinePeriodonticsOral lichen planusOral Surgerymedicine.symptombusinessJournal of Oral Pathology &amp; Medicine
researchProduct

Hidden coeliac disease in patients suffering from oral lichen planus.

2011

Letter to Editor

Celiac DiseaseDiet Gluten-FreeSettore MED/09 - Medicina InternaCoeliac disease Oral Lichen PlanusSettore MED/28 - Malattie OdontostomatologicheHumansFemaleLichen Planus Oral
researchProduct

Prevalence of vulval lichen planus in a cohort of women with oral lichen planus: an interdisciplinary study

2006

Summary Background  Lichen planus (LP) is a mucocutaneous inflammatory dermatosis that frequently involves the oral and genital mucosae. Patients with LP affecting these sites are often seen by oral medicine specialists or gynaecologists who work in isolation and depend heavily on histopathologists to help them in confirming the diagnosis. There are few studies in the literature combining the experiences of these specialists who share the care of patients with both oral and genital LP. Objectives  To estimate the prevalence of vulval LP (VLP) in a cohort of patients with histologically confirmed oral LP (OLP). Methods  The study group consisted of 42 women histologically diagnosed with OLP.…

Colposcopymedicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryMucocutaneous zoneDermatologyLichen sclerosusmedicine.diseaseDermatologyVulvastomatognathic diseasesmedicine.anatomical_structureBiopsyOral and maxillofacial pathologyMedicineOral lichen planusbusinessOral medicineBritish Journal of Dermatology
researchProduct

Analysis of a possible association between oral lichen planus and drug intake. A controlled study

2010

Objectives: To investigate whether daily systemic and/or topical medication contributes to the development of oral lichen planus (OLP) lesions. Study Design: The study involved 110 OLP patients and 76 control subjects, matched by age, race and sex. The analyzed data included medical records, drug intake and topical medication. Criteria for analysis of drug intake included: (1) ATC-code drug classification; (2) number of different drugs used daily in the categories of monopharmacy (1 drug), minor polypharmacy (2 4 drugs), and major polypharmacy (> 5 drugs); and (3) drugs implicated in lichenoid reactions (DILRs). Results: Sixty (54.5%) of the 110 OLP patients reported daily medication (prior…

DrugAdultMalemedicine.medical_specialtymedia_common.quotation_subjectLesionstomatognathic systemOral administrationInternal medicinemedicineHumansGeneral Dentistrymedia_commonAgedPolypharmacyAged 80 and overbusiness.industryIncidence (epidemiology)Medical recordMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryTopical medicationstomatognathic diseasesOtorhinolaryngologyCase-Control StudiesUNESCO::CIENCIAS MÉDICASSurgeryOral lichen planusFemalemedicine.symptombusinessLichen Planus Oral
researchProduct